Related Experiment Video
Updated: Jul 17, 2025
08:32
CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
Published on: August 9, 2022
3.6K
Gene Therapy for Hemoglobinopathies.
Maria Rosa Lidonnici1, Samantha Scaramuzza1, Giuliana Ferrari1,2
1San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET), San Raffaele Scientific Institute, Milan, Italy; and.
Human Gene Therapy
|September 7, 2023
Summary
Genetic therapies are advancing for blood disorders like beta-thalassemia and sickle cell disease. Ex vivo gene therapy using engineered stem cells offers new hope for patients with these severe hemoglobinopathies.
Area of Science:
- Hematology
- Genetics
- Molecular Biology
Background:
- Beta-thalassemia and sickle cell disease are severe, inherited blood disorders affecting red blood cells.
- These autosomal recessive conditions result from mutations in the adult beta-globin gene and have global prevalence.
- Current treatments like bone marrow transplantation are limited, creating a significant unmet medical need.
Purpose of the Study:
- To review the development of ex vivo gene therapy for hemoglobinopathies.
- To discuss clinical trial outcomes and emerging gene editing technologies.
Main Methods:
- Review of ex vivo gene therapy development processes.
- Analysis of clinical trial data for gene therapy in hemoglobinopathies.
- Examination of novel gene editing tools like CRISPR-Cas9.
Main Results:
- Ex vivo gene therapy development has progressed significantly.
- Clinical trials show promise for engineered autologous hematopoietic stem cells.
- Advanced gene editing tools are enhancing therapeutic approaches.
Conclusions:
- Ex vivo gene therapy represents a promising avenue for treating beta-thalassemia and sickle cell disease.
- Engineering autologous hematopoietic stem cells offers a potentially curative strategy.
- Cutting-edge gene editing technologies are poised to revolutionize hemoglobinopathy treatment.
Related Concept Videos
00:59Gene Therapy
25.5K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.5K
01:24Hemoglobin
3.7K
Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
3.7K
01:22Bone Marrow Sampling and Transplants
356
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
356
01:28Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K
02:45Blood Transfusion and Agglutination
10.9K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.9K
01:21Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K